Shengli Xue
- Hematology top 5%
- Oncology top 10%
- Molecular Biology
- Genetics
- Public Health, Environmental and Occupational Health top 10%
- Topics
- Acute Myeloid Leukemia Research (53 papers)Acute Lymphoblastic Leukemia research (32 papers)Hematopoietic Stem Cell Transplantation (24 papers)
- Cited by
- HematologyOncologyGenetics
- Journals
- Proceedings of the National Academy of SciencesSHILAP Revista de lepidopterologíaBlood
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Shengli Xue
98 papers receiving 791 citations
Peers
Comparison fields: 5 of 74
- Hematology 354
- Oncology 319
- Molecular Biology 279
- Genetics 177
- Public Health, Environmental and Occupational Health 173
Countries citing papers authored by Shengli Xue
This map shows the geographic impact of Shengli Xue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengli Xue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengli Xue more than expected).
Fields of papers citing papers by Shengli Xue
This network shows the impact of papers produced by Shengli Xue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengli Xue. The network helps show where Shengli Xue may publish in the future.
Co-authorship network of co-authors of Shengli Xue
This figure shows the co-authorship network connecting the top 25 collaborators of Shengli Xue. A scholar is included among the top collaborators of Shengli Xue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengli Xue. Shengli Xue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 1 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 8 | |
| 9 | 4 | |
| 10 | 6 | |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | Rapid and Efficient Response to Gilteritinib and Venetoclax-Based Therapy in Two AML Patients with FLT3-ITD Mutation Unresponsive to Venetoclax Plus Azacitidine | 4 |
| 16 | 1 | |
| 17 | 10 | |
| 18 | 2 | |
| 19 | 4 | |
| 20 | [Interdigitating dendritic cell sarcoma-a case report with literature review]. | 3 |
About Shengli Xue
Shengli Xue is a scholar working on Hematology, Genetics and Oncology, having authored 115 papers that have together received 804 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (53 papers), Acute Lymphoblastic Leukemia research (32 papers) and Hematopoietic Stem Cell Transplantation (24 papers). The work is most often cited by research in Hematology (354 citations), Oncology (319 citations) and Genetics (103 citations). Shengli Xue has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Carla Heise, David H. Kirn, Depei Wu, Haiping Dai, Xiaowen Tang, Songbai Liu, Aining Sun, Huiying Qiu, Xiao Ma and Liqing Kang. Their work appears in journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.